Xtant Medical (XTNT) stock price, revenue, and financials

Xtant Medical market cap is $165.6 m, and annual revenue was $53.34 m in FY 2020

$165.6 M

XTNT Mkt cap, 19-Apr-2021

$53.3 M

Xtant Medical Revenue FY, 2020
Xtant Medical Gross profit (FY, 2020)34.4 M
Xtant Medical Gross profit margin (FY, 2020), %64.5%
Xtant Medical Net income (FY, 2020)-7 M
Xtant Medical EBIT (FY, 2020)-751 K
Xtant Medical Cash, 31-Dec-20202.3 M
Xtant Medical EV183.5 M

Xtant Medical Revenue

Xtant Medical revenue was $53.34 m in FY, 2020

Embed Graph

Xtant Medical Income Statement

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

7.4m7.2m7.7m8.2m8.9m8.6m8.3m7.9m8.9m8.9m8.5m9.5m9.9m17.7m21.0m21.5m23.1m22.1m21.4m19.8m17.9m18.7m17.3m16.7m15.3m15.7m14.8m10.5m14.0m

Cost of goods sold

1.7m1.3m1.9m2.3m2.6m3.1m3.6m3.3m3.4m3.3m3.5m3.4m6.0m6.9m6.8m7.1m7.2m7.9m8.4m5.7m6.3m5.7m5.9m5.4m5.2m5.2m4.0m4.8m

Gross profit

5.6m5.9m5.8m5.9m6.3m5.5m4.7m4.6m5.5m5.6m6.0m6.5m11.7m14.1m14.7m16.0m14.9m13.5m11.4m12.2m12.5m11.5m10.8m9.9m10.5m9.6m6.6m9.2m

Gross profit Margin, %

76%82%76%72%71%64%57%58%62%63%63%66%66%67%69%69%68%63%57%68%67%67%65%65%67%65%62%66%

Sales and marketing expense

4.3m4.8m4.1m3.8m3.4m3.8m4.2m4.1m4.1m4.4m3.9m4.7m5.0m8.4m10.5m10.4m11.2m11.0m11.1m8.9m8.3m8.5m7.8m6.7m6.1m6.7m6.4m3.9m5.3m

R&D expense

254.6k322.3k378.3k433.6k291.2k794.5k899.6k783.9k928.9k698.6k640.0k504.2k414.0k418.0k347.0k262.0k210.0k203.0k245.0k111.0k176.0k

General and administrative expense

1.4m2.1m2.6m2.3m2.4m2.9m2.3m2.8m2.3m2.1m2.3m2.4m2.4m4.0m3.5m3.9m3.8m4.1m4.5m3.3m3.0m3.4m2.5m4.2m4.0m4.2m4.3m2.9m3.0m

Operating expense total

6.0m7.8m7.2m6.2m6.1m6.7m6.6m7.0m6.7m6.9m6.7m7.8m7.9m16.5m16.5m16.8m17.9m17.5m18.2m14.9m13.9m14.7m13.0m11.5m10.5m11.2m11.0m6.9m8.5m

Depreciation and amortization

157.0k213.2k119.1k97.9k75.1k82.4k58.8k124.1k100.7k1.5m1.2m1.2m1.3m1.3m1.5m1.4m1.0m1.0m1.0m159.0k146.0k137.0k

EBIT

(280.0k)(1.6m)(1.3m)(347.4k)212.7k(1.2m)(1.9m)(2.3m)(1.2m)(1.3m)(1.3m)(1.7m)(1.4m)(4.9m)(2.4m)(2.1m)(1.9m)(2.6m)(4.7m)(3.5m)(1.7m)(2.3m)(1.4m)(668.0k)(563.0k)(705.0k)(1.4m)(387.0k)760.0k

EBIT margin, %

(4%)(22%)(17%)(4%)2%(14%)(23%)(30%)(13%)(15%)(15%)(18%)(14%)(28%)(11%)(10%)(8%)(12%)(22%)(18%)(9%)(12%)(8%)(4%)(4%)(4%)(9%)(4%)5%

Interest expense

132.9k541.2k142.9k266.2k867.9k1.1m1.2m2.0m2.9m568.4k1.5m2.4m1.5m2.1m3.2m2.3m3.2m3.2m5.0m3.8m3.6m2.7m1.7m2.1m1.4m1.2m

Pre tax profit

(405.3k)(3.2m)(1.0m)730.5k(2.5m)(1.7m)(2.5m)(4.4m)(2.8m)(1.9m)(1.9m)(2.5m)(2.4m)(1.3m)

Income tax expense

(23.0k)22.0k23.0k22.0k23.0k23.0k

Net Income

(405.3k)(3.2m)(1.0m)730.5k(2.5m)(1.7m)(2.5m)(4.4m)(4.1m)(1.9m)(1.2m)(4.2m)(2.9m)(5.6m)(4.5m)(5.8m)(9.7m)(5.3m)(5.0m)(3.2m)(2.8m)(1.9m)(1.9m)(2.5m)(2.5m)(1.4m)

Xtant Medical Balance Sheet

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

1.4m1.8m1.4m1.2m8.6m2.1m5.1m3.4m4.8m3.0m7.0m2.9m2.0m8.0m4.7m2.2m1.4m2.5m1.7m2.1m6.2m6.0m5.1m7.1m7.3m5.7m3.2m3.0m2.7m

Accounts Receivable

5.5m6.4m7.6m6.6m7.2m7.2m6.2m4.6m5.5m4.9m4.3m5.5m5.6m13.3m14.9m14.7m15.8m16.3m15.8m13.9m10.3m10.4m9.9m9.5m8.6m9.1m9.7m7.6m7.3m

Prepaid Expenses

480.2k410.6k421.3k586.0k630.4k742.8k667.9k486.7k981.5k1.0m808.2k885.4k1.0m1.0m858.4k1.3m2.0m1.7m831.2k664.6k1.1m801.0k738.0k464.0k592.0k714.0k1.1m899.0k1.7m

Inventories

6.4m7.7m10.4m12.3m13.4m13.6m13.8m13.2m10.5m10.5m11.1m9.7m9.4m22.0m24.2m25.5m26.5m26.4m24.9m24.0m22.5m22.4m22.2m16.5m15.8m16.0m18.0m19.9m20.7m

Current Assets

14.5m17.0m19.8m20.7m29.8m23.6m25.8m21.8m21.8m19.4m23.2m19.0m18.0m44.4m44.7m43.7m45.8m46.8m43.3m40.7m40.1m39.7m37.9m33.6m32.3m31.6m32.1m31.4m32.4m

PP&E

3.4m3.5m4.1m4.5m4.9m5.5m5.5m5.3m5.0m4.9m4.8m4.5m4.4m11.4m13.8m15.6m16.0m14.6m13.4m11.5m9.3m8.9m8.1m6.4m5.6m5.1m4.3m4.3m4.1m

Goodwill

728.6k728.6k728.6k728.6k728.6k728.6k728.6k24.0m41.5m41.5m41.5m41.5m41.5m41.5m41.5m41.5m41.5m3.2m3.2m3.2m3.2m3.2m3.2m

Total Assets

19.8m23.4m26.7m28.5m38.4m32.7m35.1m31.0m31.2m28.4m31.8m27.4m26.4m126.2m141.4m141.3m142.4m139.1m133.7m128.5m104.8m102.8m99.3m47.1m44.5m43.0m42.6m41.7m42.4m

Accounts Payable

2.5m2.2m3.9m3.6m4.1m4.0m4.2m3.2m4.2m4.2m3.9m4.4m4.6m7.5m12.4m12.8m12.9m8.9m8.4m7.4m7.5m7.5m5.9m6.0m3.2m2.2m3.6m3.1m2.8m

Short-term debt

907.1k1.1m2.3m4.3m44.5k45.6k46.3k212.9k218.7k195.9k159.2k82.5k95.1k100.4k30.2k5.7m8.6m10.6m302.1k65.9m383.0k469.0k478.0k73.0m337.0k229.0k401.0k408.0k415.0k

Current Liabilities

6.5m7.5m11.5m11.8m8.8m8.4m9.5m8.9m11.6m9.8m9.4m10.4m10.3m16.7m25.6m25.6m28.5m28.9m20.8m87.2m12.0m12.4m10.4m11.3m9.9m9.1m10.1m9.5m9.3m

Long-term debt

4.3m7.1m6.0m6.4m14.2m14.7m15.3m16.2m19.7m20.1m20.5m21.3m21.7m112.3m112.4m116.2m119.1m51.8m64.0m71.4m77.2m79.8m76.2m75.0m75.6m76.8m79.0m79.0m81.0m

Total Debt

5.2m8.2m8.3m10.6m14.3m14.8m15.4m47.0k48.4k49.2k49.9k21.4m52.4k53.2k30.2k203.6k209.8k259.0k302.1k319.1k383.0k469.0k478.0k148.0m76.0m77.0m79.4m79.5m81.5m

Total Liabilities

10.8m14.7m17.7m18.3m29.9m30.1m31.7m31.7m37.8m36.4m36.3m37.9m38.2m129.1m138.0m141.8m147.5m151.4m155.6m158.7m89.2m92.2m86.6m86.2m85.6m85.9m89.0m88.5m90.4m

Common Stock

38.040.043.043.043.043.052.052.055.06.07.07.07.011.011.011.011.018.018.018.0

Preferred Stock

Additional Paid-in Capital

41.4m44.3m50.0m50.4m51.4m52.0m55.3m55.6m57.9m58.4m63.1m64.6m66.1m81.8m82.0m82.6m82.9m86.0m86.1m86.3m165.8m165.8m171.0m178.7m178.7m178.8m179.3m181.4m181.6m

Retained Earnings

(32.4m)(35.6m)(41.0m)(40.3m)(42.8m)(49.3m)(51.8m)(56.2m)(64.5m)(66.4m)(67.6m)(75.0m)(77.9m)(84.6m)(78.6m)(83.1m)(88.0m)(98.3m)(108.0m)(116.5m)(150.2m)(155.5m)(158.4m)(217.8m)(219.8m)(221.7m)(225.8m)(228.3m)(229.6m)

Total Equity

9.0m8.7m9.0m10.1m8.6m2.7m3.4m(636.0k)(6.6m)(8.0m)(4.5m)(10.5m)(11.8m)(2.8m)3.4m(496.3k)(5.1m)(12.3m)(21.9m)(30.2m)15.6m10.6m12.7m(39.2m)(41.1m)(42.9m)(46.5m)(46.9m)(48.0m)

Debt to Equity Ratio

0.6 x0.9 x0.9 x1 x1.7 x5.6 x4.5 x-0.1 x0 x0 x0 x-2 x0 x0 x0 x-0.4 x0 x0 x0 x0 x0 x0 x0 x-3.8 x-1.8 x

Debt to Assets Ratio

0.3 x0.4 x0.3 x0.4 x0.4 x0.5 x0.4 x0 x0 x0 x0 x0.8 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x3.1 x1.7 x

Financial Leverage

2.2 x2.7 x3 x2.8 x4.5 x12.3 x10.2 x-48.8 x-4.8 x-3.6 x-7.1 x-2.6 x-2.2 x-44.6 x42.1 x-284.7 x-27.9 x-11.3 x-6.1 x-4.2 x6.7 x9.7 x7.8 x-1.2 x-1.1 x-1 x-0.9 x-0.9 x-0.9 x

Xtant Medical Cash Flow

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

4.5m1.3m(1.0m)(316.3k)(2.8m)(1.7m)(4.2m)(8.5m)(4.1m)(6.0m)(7.2m)(4.2m)(7.1m)(13.8m)(5.6m)(10.1m)(15.0m)(5.8m)(15.5m)(24.0m)(5.3m)(10.3m)(13.4m)(2.8m)(4.7m)(6.6m)(2.5m)(5.0m)(6.3m)

Depreciation and Amortization

590.1k803.3k213.5k403.3k577.1k200.4k394.8k586.8k169.1k345.6k498.3k235.1k446.8k2.4m1.8m3.6m5.6m2.1m4.2m7.4m1.6m3.2m7.5m776.0k1.6m2.3m685.0k1.2m1.7m

Accounts Receivable

(1.9m)(2.9m)(525.7k)524.2k(237.8k)(106.9k)156.3k971.0k(836.6k)(220.5k)346.2k(993.8k)(1.1m)(2.8m)328.3k207.9k(859.0k)2.5m2.5m4.1m2.3m2.2m2.8m403.0k1.4m417.0k195.0k2.3m2.5m

Inventories

(883.2k)(1.5m)(2.0m)(3.9m)(5.1m)(455.8k)(148.9k)265.4k238.6k306.9k(350.2k)147.7k209.8k477.8k(1.1m)(2.7m)(4.0m)261.2k1.2m1.7m(182.0k)(388.0k)(508.0k)623.0k955.0k760.0k(2.0m)(4.2m)(5.0m)

Accounts Payable

(353.8k)(200.0k)1.3m1.0m1.3m(145.0k)307.8k(636.0k)1.4m1.0m884.4k610.7k742.8k694.3k3.7m3.7m3.2m(1.7m)(2.4m)(3.4m)(1.9m)(1.9m)(3.6m)(429.0k)(3.5m)(4.2m)1.4m884.0k626.0k

Cash From Operating Activities

(4.4m)(6.4m)(2.9m)(4.9m)(7.8m)(2.3m)(3.6m)(5.2m)(2.2m)(3.9m)(5.2m)(2.1m)(4.1m)(9.0m)1.0m(7.8m)(11.2m)436.2k(756.7k)(1.2m)236.0k344.0k(779.0k)490.0k954.0k(342.0k)(1.8m)(1.6m)(1.6m)

Purchases of PP&E

(269.4k)(549.3k)(347.7k)(870.6k)(1.2m)(477.8k)(579.9k)(633.4k)(54.9k)(115.2k)(190.6k)(48.8k)(70.4k)(444.3k)(2.7m)(4.4m)(5.6m)(310.1k)(1.1m)(1.5m)(132.0k)(288.0k)(308.0k)(137.0k)(211.0k)(403.0k)(258.0k)(673.0k)(907.0k)

Cash From Investing Activities

(377.5k)(599.0k)(347.7k)(870.6k)(1.2m)(477.8k)(590.1k)(643.5k)(18.9k)(79.1k)(180.5k)(32.4k)(54.0k)(73.4m)(2.7m)(4.4m)(5.6m)(310.1k)(1.1m)(1.5m)(132.0k)(288.0k)(57.0k)(86.0k)(48.0k)(162.0k)(175.0k)(567.0k)(734.0k)

Short-term Borrowings

(154.6k)(10.4m)(10.4m)

Long-term Borrowings

(86.2k)(5.1m)(10.7k)(445.5k)(9.8m)(12.0k)(22.9k)(144.4k)(70.0k)(107.2k)(619.4k)(208.0k)(90.2k)(117.2k)(8.0k)(49.4k)(80.1k)(63.0k)(27.9k)(203.4k)(79.0k)(167.0k)(260.0k)(104.0k)(277.0k)(395.0k)(34.0k)(75.0k)(115.0k)

Cash From Financing Activities

5.9m8.5m3.9m6.2m16.9m(47.6k)4.4m4.3m3.9m3.9m9.3m542.0k1.7m85.8m(8.0k)8.0m11.8m(217.6k)910.9k2.1m3.2m3.1m3.0m(104.0k)(385.0k)(544.0k)(34.0k)(75.0k)(115.0k)

Net Change in Cash

1.1m1.5m612.5k462.5k7.9m(2.8m)209.9k(1.5m)1.7m(56.9k)3.9m(1.6m)(2.4m)3.4m(1.7m)(4.2m)(5.0m)(91.4k)(913.7k)(509.2k)3.3m3.2m2.2m300.0k521.0k(1.0m)(2.0m)(2.2m)(2.5m)

Interest Paid

483.3k815.0k1.9m2.2m

Income Taxes Paid

Xtant Medical Ratios

USDQ2, 2011

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

2.2 x

Xtant Medical Employee Rating

2.517 votes
Culture & Values
2.5
Work/Life Balance
2.9
Senior Management
1.9
Salary & Benefits
2.4
Career Opportunities
2.3
Source